Cuatrecasas advises Columbus Partners and Mérieux Equity Partners on their investment in Ona Therapeutics, which is developing new cancer treatments

by Cuatrecasas

Cuatrecasas advised Columbus Venture Partners and Mérieux Equity Partners on their participation as co-lead investors in Ona Therapeutics Series B financing. Ona Therapeutics is a pioneering biopharm...

Read more

CDTI Innovación invests in Ona Therapeutics, together with five co-investors

by CDTI Innovación

Ona Therapeutics is a pioneer in the development of first-in-class antibody-drug conjugates (ADCs) that leverage the molecular basis of advanced cancer. Through collaboration with academic and clinica...

Read more

Three Asabys-Backed Biotechs Featured in Nature, Showcasing Spain's Scientific Innovation

by Asabys Partners

Nature, the world's leading scientific journal, has spotlighted three Barcelona-based biotech startups, Ona Therapeutics, Nuage Therapeutics, and SpliceBio, in a recent article highlighting Spain's bu...

Read more

Ona Therapeutics raises €30M in Series A financing supported by Alta Life Sciences, Asabys Partners, Bpifrance – InnoBio 2, Fund+ and Ysios Capital

by Asabys Partners

Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today the closing of a €30 million Series A financing, with the par...

Read more

Ona Therapeutics cierra una ronda de 1,5 millones de euros aportados por Asabys Partners

by Asabys Partners

Ona Therapeutics ha anunciado el cierre de una ronda de financiación semilla de 1,5 millones de euros aportados en su totalidad por Sabadell Asabys, vehículo gestionado por Asabys Partners dedicado ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Citring closes a €920,000 funding roun...

by Faraday Venture Partners

Citring began operations in late 2017 and passed through Lanzadera, on...

Photos Stream